Navigation Links
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
Date:2/8/2010

License will accelerate the development of prostratin—the first in a new class of drugs for the treatment of HIV/AIDS.

(PRWEB) February 8, 2010 --AIDS Research Alliance announced today the signing of a new licensing agreement with Stanford University, transferring exclusive rights of a novel technology developed by Dr. Paul Wender and colleagues of Stanford to AIDS Research Alliance. This new technology (Science, Vol 320, p 649-652, 2 May 2008) will allow AIDS researchers to synthesize the natural compound, prostratin. Early tests conducted at the National Cancer Institute (NCI) and on-going pre-clinical studies conducted by AIDS Research Alliance indicate that prostratin targets latent HIV—the virus not killed by existing anti-HIV therapies. Previously, prostatin had to be collected from natural resources—an expensive and cumbersome process.



“Dr. Wender’s genius removes a major hurdle to the therapeutic development of this promising compound,” said Carolyn H. Carlburg, President & CEO of AIDS Research Alliance. The ability to produce prostratin synthetically will significantly reduce future costs, making prostratin a more viable drug candidate, Carlburg said.

“When used in combination with existing antiretroviral drugs, prostratin may one day help treating physicians eradicate all virus from the body—a feat not yet possible using existing therapies,” stated Dr. Stephen J. Brown, Medical Director at AIDS Research Alliance.

Dr Brown explains: “Current therapies suppress the virus, but they do not completely eradicate virus from the body. Rather, some viral particles lay dormant in pockets or “reservoirs,” avoiding the reach of today’s anti-HIV drugs. When existing treatments are interrupted, the HIV reservoir floods the body with new virus, re-igniting the infection. Thus, no cure for AIDS is possible without emptying the HIV reservoir.”

“AIDS Research Alliance has the only new drug in development that targets the HIV reservoir,” states Dr. Brown. AIDS Research Alliance has been studying how to flush virus from the HIV reservoir for more than a decade, said Dr. Brown.    

If approved by the U.S. Food & Drug Administration (FDA), prostratin would be the first in a new class of drugs and unveil a novel way to treat HIV/AIDS, Carlburg says.    

AIDS Research Alliance on Wikipedia

About AIDS Research Alliance. AIDS Research Alliance is the nation’s only independent, not-for-profit research organization licensed by the National Institutes of Health to develop an anti-HIV drug. AIDS Research Alliance helped to develop about half of current anti-HIV drugs. AIDS Research Alliance conducts research seeking an HIV vaccine and a cure for AIDS. The U.S. Food & Drug Administration conducted a preliminary review of AIDS Research Alliance’s prostratin data in February 2009. Additional pre-clinical studies will continue over the next year.    

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3532854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Marijuana ineffective as an Alzheimers treatment: UBC-Vancouver Coastal Health research
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. Developing a cyberinfrastructure for comparative effectiveness in cancer research
9. Women should be allowed to eat, drink during labor: Queens University researcher
10. Parkinsons disease research uncovers social barrier
11. Fear of Frailty: Research Shows Lack of Activity Threatens Seniors' Independence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
Breaking Medicine Technology: